SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001437749-19-022972
Filing Date
2019-11-15
Accepted
2019-11-14 17:55:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 dffn20191113_424b4.htm 424B4 289602
2 dffn20191014_s1img002.jpg GRAPHIC 28906
3 dffn20191014_s1img003.gif GRAPHIC 46901
4 dffn20191014_s1img004.gif GRAPHIC 47314
5 image01.jpg GRAPHIC 10362
  Complete submission text file 0001437749-19-022972.txt   475253
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-234234 | Film No.: 191221877
SIC: 2834 Pharmaceutical Preparations